Research Topics
Genomes and GenesSpecies | Kathy DujardinSummaryAffiliation: CHRU de Lille Country: France Publications
| Collaborators
|
Detail Information
Publications
[Apathy an neurodegenerative diseases: pathophysiology, diagnostic evaluation, and treatment]K Dujardin
Faculte de Medecine, Université du Droit et de la Santé de Lille, Institut Fédératif de Recherche IFR 114, Neurosciences, Cedex
Rev Neurol (Paris) 163:513-21. 2007..The treatment of apathy per se remains anecdotal and, to date, little research into the efficacy of medication therapy has been performed...
Is the paced auditory serial addition test (PASAT) a valid means of assessing executive function in Parkinson's disease?Kathy Dujardin
Neurology and Movement Disorders Unit, Faculty of Medicine and Lille University Hospital, Lille, France
Cortex 43:601-6. 2007..Our results demonstrate the high sensitivity of the PASAT to cognitive impairment. However, correlation analyses showed that the main factor explaining the PD patients' PASAT impairment was cognitive slowing...
Characteristics of apathy in Parkinson's diseaseKathy Dujardin
Neurology and Movement Disorders Unit, EA2683, Faculty of Medicine and Lille University Hospital, Lille, France
Mov Disord 22:778-84. 2007..Although the neurochemical substrate of apathy remains poorly characterized, the strong link between apathy and cognitive impairment observed in several studies suggests the participation of nondopaminergic circuits...
The Lille Apathy Rating Scale: validation of a caregiver-based versionKathy Dujardin
Neurology and Movement Disorders Unit, EA2683, Faculty of Medicine and Lille University Hospital, Lille, France
Mov Disord 23:845-9. 2008..The LARS-i was seen to have excellent psychometric properties and appears to be valid for use in PD with respect to the patient-based LARS and the informant- and clinician-rated versions of the AES...
Cognitive complaints in Parkinson's disease: its relationship with objective cognitive declineKathy Dujardin
Neurology and Movement Disorders Unit, EA2683, Faculty of Medicine and University Medical Center, Lille, France
J Neurol 257:79-84. 2010..However, the CCI does not enable more accurate screening for PD-associated dementia...
Apathy may herald cognitive decline and dementia in Parkinson's diseaseKathy Dujardin
Universite Lille Nord de France, France
Mov Disord 24:2391-7. 2009..These findings suggest that in nondemented, nondepressed PD patients, apathy may be a predictive factor for dementia and cognitive decline over time...
Deficits in decoding emotional facial expressions in Parkinson's diseaseKathy Dujardin
Neurology A Department, Neurology and Movement Disorders Unit, Salengro Hospital, EA 2683, Lille University Hospital, F 59037 Lille Cedex, France
Neuropsychologia 42:239-50. 2004..The aim of the present study was to assess the consequences of Parkinson's disease (PD) on ability to decode emotional facial expressions (EFEs)-a method commonly used to investigate non-verbal emotion processing...
Role of basal ganglia circuits in resisting interference by distracters: a swLORETA studyPerrine Bocquillon
University of Lille Nord de France, Lille, France
PLoS ONE 7:e34239. 2012..Three-stimulus oddball paradigms can be used to study distracter-elicited and target-elicited P300 subcomponents...
Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patientsMelissa Tir
Department of Neurology, Salengro Hospital, Lille University Medical Centre, Lille, France
Neurosurgery 61:297-304; discussion 304-5. 2007..The primary objective was to describe the clinical outcome in terms of efficacy and tolerance in STN-DBS patients. A secondary objective was to discuss presurgery clinical characteristics a posteriori as a function of outcome...
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled studyDavid Devos
Department of Neurology, IFR114, Institute of Predictive Medicine and Therapeutic Research, Lille University Hospital, Lille, France
Mov Disord 23:850-7. 2008..A predominantly noradrenergic tricyclic antidepressant induced a more intense short-term effect on parkinsonian depression than did an SSRI. However, desipramine's lower tolerability may outweigh its slight short-term clinical advantage...
Use of swLORETA to localize the cortical sources of target- and distracter-elicited P300 componentsPerrine Bocquillon
Universite Lille Nord de France, UDSL, Ibis Rue Georges Lefevre 59000 Lille, France
Clin Neurophysiol 122:1991-2002. 2011..Cognitive event-related potentials (especially P300) have long been used to explore attentional processes. The aim of this study was to identify the cortical areas involved in P300 generation during a selective attention task...
Subthalamic nucleus stimulation induces deficits in decoding emotional facial expressions in Parkinson's diseaseK Dujardin
Neurology and Movement Disorders Unit, EA2683, University of Lille 2 and Lille University Hospital, Lille, France
J Neurol Neurosurg Psychiatry 75:202-8. 2004..Although adverse effects are infrequent, some behavioural disturbances have been reported...
Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's diseaseKathy Dujardin
Neurology and Movement Disorders Unit, Faculty of Medicine and Lille University Hospital, EA2683, Lille, France
J Neurol 253:1154-9. 2006....
A case of severe dysexecutive syndrome consecutive to chronic bilateral pallidal stimulationK Dujardin
Neurologie A, CHRU de Lille, Hopital Salengro, 59037 Lille, Cedex, France
Neuropsychologia 38:1305-15. 2000..When the stimulation was turned off, the impairment was partly reversible. This observation emphasizes the role of the GPi in executive function...
Parkinson's disease dementia can be easily detected in routine clinical practiceKathy Dujardin
Universite Lille Nord de France, UDSL, CNRS FRE3291, Neurology and Movement Disorders Unit, Lille University Medical Center, Lille, France
Mov Disord 25:2769-76. 2010....
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot studyCaroline Moreau
Département de Pharmacologie médicale, Universite Lille Nord de France, CHRU de Lille, Lille F 59037, France
J Neurol Neurosurg Psychiatry 84:552-5. 2013..Given that memantine is thought to decrease N-methyl-D-aspartic-acid-related (NMDA) glutamatergic hyperactivity and improve locomotion in rats, we sought to assess the drug's impact on axial symptoms in advanced Parkinson's disease (PD)...
The pattern of attentional deficits in Parkinson's diseaseKathy Dujardin
Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, University of Lille 2, Lille, France
Parkinsonism Relat Disord 19:300-5. 2013..We also sought to identify the main demographic and clinical characteristics associated with attention deficits in Parkinson's disease...
Methylphenidate : a treatment for Parkinson's disease?David Devos
Department of Medical Pharmacology, EA 1046, Lille Nord de France University, CHU Lille, Lille, France
CNS Drugs 27:1-14. 2013..Pharmacogenetic tools could be of use in better defining study patients as a function of their dopaminergic metabolism and drug responsiveness...
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trialCaroline Moreau
Department of Movement Disorders and Neurology, Lille Nord de France University, CHU Lille, Lille, France
Lancet Neurol 11:589-96. 2012....
Executive function differences in multiple system atrophy and Parkinson's diseaseKathy Dujardin
Neurology and Movement Disorders Unit, Clinique Neurologique, Neurologie A, Hopital Salengro, CHRU de Lille, 59037 Lille Cedex, France
Parkinsonism Relat Disord 9:205-11. 2003..This study suggests that despite the evidence of some differences in executive function in MSA and PD, the contribution of standard neuropsychological examination to the differential diagnosis of both syndromes remains still limited...
Role of attentional resources on gait performance in Huntington's diseaseArnaud Delval
Department of Neurology and Movement Disorders, Salengro Hospital, Lille Regional University Hospital, Lille Cedex, France
Mov Disord 23:684-9. 2008..Patients with HD had greater difficulty walking while performing a concurrent cognitive task; the drain on attentional resources deteriorated walking performance...
Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoonClemence Simonin
Department of Neurology and Movement Disorders, Salengro Hospital, EA 2683, Lille University Medical Center, Lille, France
J Neurol 256:1736-41. 2009..Our results suggest that DBS leads to both qualitative and quantitative modulations in the corticostriatal loops...
[Classification of parkinsonian syndromes via factorial discriminant analysis of brain SPECT data]A Kreisler
EA 2683, Service de Neurologie et Pathologie du Mouvement, Hopital Roger Salengro, CHU de Lille, 59037 Lille Cedex, France
Rev Neurol (Paris) 165:440-8. 2009....
[Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: an open label study]H Zephir
Clinique Neurologique, Hopital Roger Salengro, CHRU de Lille, université Lille 2 EA 2686, 59047 Lille Cedex, France
Rev Neurol (Paris) 164:47-52. 2008..We suggest that mitoxantrone combined with methylprednisolone has a potential positive effect on cognitive functions...
Gait abnormalities induced by acquired bilateral pallidal lesions: a motion analysis studyP Krystkowiak
Neurologie A, Hopital R Salengro, CHRU de Lille, 59037, Lille Cedex, France
J Neurol 253:594-600. 2006..However, the precise clinical features of these disorders (and the role of the pallidum therein) remain to be established...
Stimulation of the subthalamic nucleus in Parkinson's disease: cognitive and affective changes are not linked to the motor outcomeM P Perriol
Neurology and Movement Disorders Unit, EA2683, University of Lille 2 and Lille University Hospital, Lille, France
Parkinsonism Relat Disord 12:205-10. 2006..Subthalamic nucleus deep brain stimulation (STN0 DBS) is a widely performed surgical treatment in PD. However, the relationship between motor results and cognitive/behavioural modifications is unclear...
The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's diseaseP Sockeel
Psychology Department, Charles De Gaulle University, and Neurology and Movement Disorders Unit, Faculty of Medicine and Lille University Hospital, France
J Neurol Neurosurg Psychiatry 77:579-84. 2006..It is a frequent consequence of neurological and psychiatric disorders. Although various scoring methods have been proposed, there is a lack of validated, standardised instruments for detecting apathy and assessing its severity...
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's diseaseD Devos
Department of Neurology, Institute of Predictive Medicine and Therapeutic Research, Lille University Medical Centre, Lille, France
J Neurol Neurosurg Psychiatry 78:470-5. 2007..Gait disorders could also be partly related to norepinephrine system impairment, and the pharmacological modulation of both dopamine and norepinephrine pathways could potentially improve the symptomatology...
Attention impairment in temporal lobe epilepsy: a neurophysiological approach via analysis of the P300 wavePerrine Bocquillon
Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France
Hum Brain Mapp 30:2267-77. 2009..Our hypothesis was that temporal lobe dysfunction would modify the P3 source regions in TLE patients...
SNCA locus duplication carriers: from genetics to Parkinson disease phenotypesEugénie Mutez
UMR 837 INSERM, Team 6, JParc, IRCL, Lille, France
Hum Mutat 32:E2079-90. 2011..Our detailed genomic analysis and clinical exploration enabled us to specify the genotype-phenotype relationship, identify a case of presymptomatic PD and gain insight into the role of LINEs in SNCA locus duplication...
The spectrum of cognitive disorders in Parkinson's disease: a data-driven approachKathy Dujardin
Laboratoire de Neurosciences Fonctionnelles et Pathologies, University of Lille 2, EA4559, Lille, France
Mov Disord 28:183-9. 2013..Our results confirm the heterogeneity of cognitive presentations in PD, ranging from cognitively intact patients with rather high levels of performance in each cognitive domain to very severely impaired patients...
Dysfunction of the human memory systems: role of the dopaminergic transmissionKathy Dujardin
Neurology and Movement Disorders Unit, Neurology A Department, Salengro Hospital, Lille University Hospital, Lille, France
Curr Opin Neurol 16:S11-6. 2003..Other neurotransmission systems are probably involved in the pathophysiology of cognitive dysfunction in Parkinson's disease, and currently it is the cholinergic hypothesis that is the most considered...
Slowly progressive spinocerebellar ataxia with extrapyramidal signs and mild cognitive impairment (SCA21)J Delplanque
INSERM U837, Jean Pierre Aubert Research Center, Lille, France
Cerebellum 7:179-83. 2008..Therefore, the gene responsible for SCA21 remains to be identified...
Clinical features and genetic analysis of a new form of spinocerebellar ataxiaD Devos
Clinique Neurologique, UF de Neurobiologie, Hopital R Salengro, CHRU, Lille, France
Neurology 56:234-8. 2001..The growing heterogeneity of the autosomal dominant forms of these diseases shows that the genetic etiologies of at least 20% of ADCA have yet to be elucidated...
Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical studyArnaud Delval
Department of Neurology and Movement, Disorders, EA 2683, Hospital R. Salengro, Regional University Hospital, 59037, Lille Cedex, France
J Neurol 253:73-80. 2006..Gait speed in HD was correlated to the motor part of the UHDRS. CONCLUSION: Gait in HD is mainly characterized by a timing disorder: bradykinesia was present, with severe intra-individual variability in temporal gait parameters...
Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patientsKathy Dujardin
Neurologie et Pathologie du Mouvement Neurologie A, Hôpital Salengro Centre Hospitalier Universitaire, 59037, Lille Cedex, France
J Neurol 251:1383-92. 2004....
Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's diseaseCanan Ozsancak
Service de Neurologie et Pathologie du Mouvement, EA 2683 Clinique Neurologique, CHU de Lille, 59037, Lille Cedex, France
J Neurol 251:1317-23. 2004....
Cognitive functions in neuromyelitis opticaFrederic Blanc
Department of Neurology, Strasbourg University, Alsace, France
Arch Neurol 65:84-8. 2008..To date, cognitive functions have never been investigated in NMO...
